Economy Paid
ARP backs Polfa expansion
04:48
The Industrial Development Agency (ARP) has approved PLN 100 million in financing for Tarchomin Pharmaceutical Works “Polfa,” a key domestic producer of antibiotics, insulin, and highly active oncology drugs. The funding will speed up Polfa’s strategic investment plan, including construction of a Center for the Development and Production of Highly Active Drugs and work on next-generation Highly Potent (HP) molecules.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
